Download video

Dr. Kunz on Sequencing Agents for Pancreatic NETs

208 views

OncLive

10 years ago

Dr. Kunz on Sequencing Agents for Pancreatic NETs

Dr. Kunz on Sequencing Agents for Pancreatic NETs

Dr. Kunz on Sequencing Agents for Pancreatic NETs
1:12
Dr. Kunz on Sequencing Agents for Pancreatic NETs
by OncLive
Dr. Kunz on Sequencing Agents for the Treatment of Pancreatic NETs
1:13
Dr. Kunz on Sequencing Agents for the Treatment of Pancreatic NETs
by Targeted Oncology
Dr. Kunz on Treatment Options for Pancreatic NETs
2:05
Dr. Kunz on Treatment Options for Pancreatic NETs
by OncLive
The Latest in Systemic Treatments \& Considerations for Treatment Sequencing • Dr. Kunz • LACNETS
21:49
The Latest in Systemic Treatments \& Considerations for Treatment Sequencing • Dr. Kunz • LACNETS
by LACNETS
Dr. Kunz on Classifying and Predicting Response in NETs
1:24
Dr. Kunz on Classifying and Predicting Response in NETs
by Targeted Oncology
Treatment Sequencing and Combinations in Pancreatic Neuroendocrine Tumors
6:00
Treatment Sequencing and Combinations in Pancreatic Neuroendocrine Tumors
by OncLive
Targeted Therapies in Pancreatic Neuroendocrine Tumors
6:01
Targeted Therapies in Pancreatic Neuroendocrine Tumors
by OncLive
SEQTOR: streptozotocin plus 5-fluorouracil and everolimus sequences in pancreatic NETs
4:08
SEQTOR: streptozotocin plus 5-fluorouracil and everolimus sequences in pancreatic NETs
by VJOncology
How to Diagnose, Treat, and Follow Neuroendocrine Tumors (NETs)
21:04
How to Diagnose, Treat, and Follow Neuroendocrine Tumors (NETs)
by OncBrothers: Practice-Changing Cancer Discussions
Introduction to Neuroendocrine Tumors. Pamela Kunz, MD, Stanford
17:52
Introduction to Neuroendocrine Tumors. Pamela Kunz, MD, Stanford
by NETRF
Challenges with Somatostatin Analogues in Neuroendocrine Tumors (NETs)
5:22
Challenges with Somatostatin Analogues in Neuroendocrine Tumors (NETs)
by Oncology Brothers Clips
Optimal Sequencing Strategy for NETs
3:58
Optimal Sequencing Strategy for NETs
by OncLive
Combination and Sequential Treatment in pNETs
9:13
Combination and Sequential Treatment in pNETs
by OncLive
Dr. Kunz on the Impact of Lanreotide’s Approval for Neuroendocrine Tumors
1:17
Dr. Kunz on the Impact of Lanreotide’s Approval for Neuroendocrine Tumors
by OncLive
What is New in Pancreatic NETs in the Last 12 Months?
18:04
What is New in Pancreatic NETs in the Last 12 Months?
by HMP Education
Dr. Kunz on the CLARINET Study for GEP-NETs
1:41
Dr. Kunz on the CLARINET Study for GEP-NETs
by OncLive
Dr. Pamela Kunz on the Effectiveness of Immunotherapies and Their Promising Future
1:01
Dr. Pamela Kunz on the Effectiveness of Immunotherapies and Their Promising Future
by Targeted Oncology
FDA-Approved Novel Agent Appears Promising in GEP-NETs
1:27
FDA-Approved Novel Agent Appears Promising in GEP-NETs
by Targeted Oncology
What About Immunotherapy, Pam Kunz, Stanford University
12:47
What About Immunotherapy, Pam Kunz, Stanford University
by NETRF
Managing pancreatic neuroendocrine tumors
1:06
Managing pancreatic neuroendocrine tumors
by VJOncology
Dr. Kunz on Potential of Immunotherapy in Neuroendocrine Tumors
1:33
Dr. Kunz on Potential of Immunotherapy in Neuroendocrine Tumors
by OncLive
Role of Next-Generation Sequencing in Neuroendocrine Tumors (NETs)
1:55
Role of Next-Generation Sequencing in Neuroendocrine Tumors (NETs)
by Oncology Brothers Clips
2: NETs Symptoms and Treatments, Dan Halperin, MD; MD Anderson, 2018 Houston Conference
43:06
2: NETs Symptoms and Treatments, Dan Halperin, MD; MD Anderson, 2018 Houston Conference
by NETRF